NIOX Group Plc (CSSPF)
NIOX Group Plc operates in the Medical - Devices industry of the Healthcare sector, headquartered in Oxford, OX, GB. The stock last traded at $0.82, up 0.00% on the session, giving a market capitalisation of $345.1M. On trailing twelve-month figures it carries a trailing P/E of 37.87, a net margin of 14.4%. Its beta of -0.09 implies it has historically moved less than the broad market.
Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
NIOX Group Plc is most often compared with the following Healthcare names: